133TiP Neoadjuvant osimertinib followed by sequential definitive radiotherapy and/or surgery in stage III EGFR-mutant NSCLC: An open-label, single-arm, phase II study
Kian, W., Peled, N., Roisman, L.C., Levison, E., Dudnik, J., Chernomordikov, E., Dudnik, E., Keren-Rosenberg, S., Tsuriel, S., Hannes, V., Hershkovitz, D., Lichtenberg, R., Granot, I., Krayim, B., Shalata, W., Allen, A.M., Blumenfeld, P., Lavrenkov, K.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article